Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
Create a narrative
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Novo Nordisk
BA
bactrian
Community Contributor
A Quality Compounder Marked Down on Overblown Fears
Novo Nordisk , a global leader in diabetes and obesity treatments, is trading at a deep discount to both its historical multiples and intrinsic value. The ADR is now priced at $47.05 , reflecting a normalized P/E ratio of just 13.4× , down from a five-year average closer to 25–30×.
View narrative
US$120.72
FV
57.7% undervalued
intrinsic discount
15.71%
Revenue growth p.a.
Set Fair Value
26
users have liked this narrative
7
users have commented on this narrative
64
users have followed this narrative
New
narrative
ASML Holding
IN
Investingwilly
Community Contributor
Why Now is the Time to buy ASML
What Does ASML Do? ASML Holding N.V. is a Dutch company and the world’s only supplier of extreme ultraviolet (EUV) lithography machines —a critical technology used to produce the world’s most advanced computer chips.
View narrative
US$1.00k
FV
28.0% undervalued
intrinsic discount
15.17%
Revenue growth p.a.
Set Fair Value
35
users have liked this narrative
6
users have commented on this narrative
94
users have followed this narrative
Updated
narrative
Wyndham Hotels & Resorts
ZW
Zwfis
Community Contributor
Wyndham Continues Global Expansion with 19% Ancillary Revenue Growth
WH is a company that I actually took interest in a couple of months ago when I happened to stay at one of their franchise hotels. I had to leave early in the morning at like 4 and when I went out to the parking lot I was astounded that in the little town I was was absolutely full.
View narrative
US$105.80
FV
20.6% undervalued
intrinsic discount
13.23%
Revenue growth p.a.
Set Fair Value
7
users have liked this narrative
2
users have commented on this narrative
14
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Beam Global
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
Expanding Off-Grid EV Charging Will Transform International Renewable Markets
Key Takeaways Diversification across products, customers, and regions reduces revenue volatility and positions Beam Global to benefit from electrification and resilience trends. Synergies from acquisitions and grid-independent technology improve efficiency, supply chain strength, and competitive pricing power, supporting sustained earnings and margin growth.
View narrative
US$3.45
FV
38.6% undervalued
intrinsic discount
14.80%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
10
users have followed this narrative
1 day ago
author updated this narrative
Protalix BioTherapeutics
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Pipeline Advancements Will Unlock Global Therapeutic Potential
Key Takeaways Expansion of rare disease therapeutics and strategic partnerships support robust product pipeline growth, diversified revenue streams, and improved commercial momentum. Regulatory incentives and a cost-efficient production platform enhance margins, accelerate market entry, and strengthen long-term earnings potential.
View narrative
US$14.00
FV
89.0% undervalued
intrinsic discount
40.40%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
23
users have followed this narrative
1 day ago
author updated this narrative
SurgePays
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
Telecom Platform And Digital Inclusion Will Foster Market Resilience
Key Takeaways Increased digitalization and government support ensure stable, recurring revenue streams, offsetting market volatility and supporting long-term earnings growth. Expansion into wholesale telecom and innovative retail solutions enhances margins, operating leverage, and cross-sell opportunities across a resilient, underserved market.
View narrative
US$9.00
FV
67.6% undervalued
intrinsic discount
114.05%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
27
users have followed this narrative
1 day ago
author updated this narrative
Heron Therapeutics
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
Hospital Adoption And Scale Will Transform Post-Surgical Care
Key Takeaways Rising hospital adoption and favorable regulatory trends bolster Heron’s pain management products, driving revenue growth, margin improvement, and long-term stability. Operational efficiencies, expanded product reach, and oncology franchise strength support reduced risk and improved overall profitability.
View narrative
US$6.25
FV
78.9% undervalued
intrinsic discount
14.06%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
11
users have followed this narrative
1 day ago
author updated this narrative
Zevra Therapeutics
AN
AnalystConsensusTarget
Consensus Narrative from 8 Analysts
Upcoming Regulatory Approvals And Clinical Launches Will Expand Accessible Markets
Key Takeaways Early success and strategic expansion with MIPLYFFA and advancing late-stage assets position Zevra for rare disease revenue growth and portfolio diversification. Strong, non-dilutive funding and international regulatory progress support independent development and commercial execution, lowering financial risk and enabling global market access.
View narrative
US$23.25
FV
48.3% undervalued
intrinsic discount
89.69%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
1
users have commented on this narrative
17
users have followed this narrative
1 day ago
author updated this narrative
Medi Assist Healthcare Services
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
Rising Healthcare Adoption And Digital Transformation Will Open International Markets
Key Takeaways Leveraging technology and unbundled services is expanding revenue streams, strengthening margins, and reducing reliance on traditional business cycles. Strategic acquisitions and international expansion position Medi Assist for accelerated growth and increased market share amidst favorable regulatory shifts.
View narrative
₹643.33
FV
15.9% undervalued
intrinsic discount
17.45%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
7
users have followed this narrative
1 day ago
author updated this narrative
Dusk Group
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Our Omnichannel Bath & Body Lines Will Drive Future Demand
Key Takeaways Enhanced product range, new categories, and collaborations position Dusk Group for sustained revenue growth and increased market share. Digital marketing investments and supply chain optimization drive online sales growth and margin improvements.
View narrative
AU$1.35
FV
29.6% undervalued
intrinsic discount
5.12%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
15
users have followed this narrative
1 day ago
author updated this narrative
PG Electroplast
AN
AnalystConsensusTarget
Consensus Narrative from 7 Analysts
Greenfield Capacity Investments And Local Manufacturing Will Boost Indian Markets
Key Takeaways Major capacity investments and automation are set to boost revenues, efficiency, and margins, positioning the company for long-term expansion and earnings quality. Strong government support and diverse, expanding client relationships reduce risks and enable sustained sales growth, increased resilience, and improved return ratios.
View narrative
₹1.04k
FV
43.1% undervalued
intrinsic discount
27.55%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
13
users have followed this narrative
1 day ago
author updated this narrative
VIK
Viking Holdings
AN
AnalystConsensusTarget
Consensus Narrative from 17 Analysts
Sustainable Fleet Expansion And New Markets Will Shape Future Success
Key Takeaways Expanding fleet, innovative vessels, and new geographic markets drive long-term growth, operational efficiency, and revenue diversification. Direct-to-consumer strategy and strong customer loyalty support premium pricing, high occupancy, and industry-leading margins.
View narrative
US$60.00
FV
5.7% undervalued
intrinsic discount
15.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
1 day ago
author updated this narrative
Value any company in seconds
Popular companies